Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
Amgen’s Clinical Trial Setback With Colon Cancer Drug, Vectibix
March 23, 2007
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
pharmamanufacturing
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Anticipating AI regulations in pharma manufacturing
FDA decisions to watch in 2024
Raising a modern pharma CDMO
2024 pharma predictions: Regulations, sustainability and culture
Pharma on top for employee pay satisfaction
Production Pulse: What's ahead for manufacturing in 2024?
Load More Content